Cancer is one of the most fatal diseases in the world, and it can hit anyone, regardless of nationality, gender, and social status. It is also a widespread disease, to the fear of many citizens, because it has dozens of types and each of them has different detrimental effects on one’s health.
However, according to statistics, the most affected by cancer is the poor, and it is not because there’s a higher rate of cancer in poor communities. It is because most cancer treatments are very expensive. More than that: Chances are, if you are poor and got stricken by cancer, you won’t be able to afford it. Mikhail Blagosklonny is one of the top oncologists in the world in the development of a cure for cancer, and he aims to chance that reality forever. His mission in life is to create cancer treatment methods that can be affordable for all and available in the entire world. Although the medical community agrees that it is a far-fetched goal, Mikhail Blagosklonny is proving the world wrong, as he continues to make progress in his quest to change cancer therapy.
Oncology is the field of science which studies the treatment of tumors. Mikhail Blagosklonny spent his whole life researching tumors, how to treat it, and, most specifically, find ways to treat cancers in the most efficient and yet affordable way. This comes with a couple of problems, like the availability of drugs for everyone and the detrimental effects that come from cheaper ingredients.
Throughout all the years of Mikhail Blagosklonny’s study and practice of oncology, his research on Rapamycin is his most impressive achievement. In a lot of cancer treatments, organ transplant is one of the best solutions to save the patient. The problem and risk involving organ transplant are that our immune system is designed to fight off foreign substances and the first ‘instinct’ of our immune system when it detects a transplanted organ is that it is a foreign substance, and so needs to be eliminated. Fortunately, Rapamycin is one of the drugs that can prevent this kind of rejection by the immune system.
Mikhail Blagosklonny considers Rapamycin a “wonder drug” because not only can it inhibit the immunity system rejecting organ transplants, it is also the primary drug approved and used for the treatment of Lymphangioleiomyomatosis or LAM. Using Tuberous Scleroris Complex gene mutations, LAM infiltrates the lung tissue and in effect activating the mTOR signaling gateway. Because of this, Lymphangiogenic growth factors are released, but, if treatment with Rapamycin is administered, Rapamycin would block the gateways. It is considered a wonder drug because of the many uses it can have for medicine.
Aside from being an immunosuppressive drug, Rapamycin is also one of the best anti-proliferative drugs because it prevents cancer cells from spreading in the body. Because of all the wonders, Rapamycin can bring to the world of oncology, Mikhail Blagosklonny is tirelessly researching more ways Rapamycin can be used in the treatment of cancer. He believes that once the full potential of Rapamycin is discovered, more affordable of treatments will be available to the people.